fda compounding semaglutide crackdown news today The FDA's GLP-1 Continues: What to Know What Patients Need to Know

Oral tablets like semaglutide offer more modest reductions of 5% to 10% but provide a highly convenient, needle-free daily alternative for managing weight safely

Wei JP, Yang CL, Leng WH, Ding LL, Zhao GH

- **60mg** -- Best value for higher-dose users (8-12mg)

Treatment discontinuation due to gastrointestinal events occurred in a minority of patients, and overall, serious adverse events were similar to those with the placebo

Part of your care team Dr

Conclusion The abdomen, front or outer thigh, and back or outer upper arm are approved GLP1 injection areas, but the best choice depends on comfort, visibility, reach, and your ability to rotate sites consistently